Featured Research

from universities, journals, and other organizations

Can Patents Stifle Innovation In Biomedical Research?

Date:
May 6, 1998
Source:
University Of Michigan
Summary:
Federal patent policy in biomedical research imposes social costs overlooked in the public debate, according to a paper by two professors at the University of Michigan Law School appearing in last week's issue of Science.

ANN ARBOR---Federal patent policy in biomedical research imposes social costs overlooked in the public debate, according to a paper by two professors at the University of Michigan Law School appearing in last week's issue of Science.

Profs. Michael A. Heller and Rebecca S. Eisenberg argue that granting too many patent rights in pre-market or "upstream" biomedical research paradoxically may stifle discovery of life-saving "downstream" products.

Biomedical research has been shifting from a commons to a privatization model, they note. Under the old model, research was publicly funded and results were made freely available in the public domain. The new model, by encouraging universities and private firms to patent their findings, has increased private investment and spurred the pace of upstream research.

However, downstream product developers now face a daunting bargaining challenge. Before they can develop new products and bring them to market, they need to collect licenses from many owners of upstream patents. These owners have conflicting priorities and conflicting assessments of relative value.

Heller and Eisenberg use property theory to explain the paradox of more patents and fewer products. Policy-makers often prescribe privatization to cure a "tragedy of the commons" in which people overuse shared resources.

But, in solving one tragedy, privatization can go astray and accidentally create a "tragedy of the anticommons" in which people underuse scarce resources because too many owners can block each other.

Examples of potential anticommons tragedies include patenting of gene fragments and royalty-stacking through the use of reach-through-license-agreements (RTLAs) for patented research tools.

According to Heller and Eisenberg, privatization of biomedical research must be more carefully deployed to promote upstream research without stifling downstream discoveries.


Story Source:

The above story is based on materials provided by University Of Michigan. Note: Materials may be edited for content and length.


Cite This Page:

University Of Michigan. "Can Patents Stifle Innovation In Biomedical Research?." ScienceDaily. ScienceDaily, 6 May 1998. <www.sciencedaily.com/releases/1998/05/980506080521.htm>.
University Of Michigan. (1998, May 6). Can Patents Stifle Innovation In Biomedical Research?. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/1998/05/980506080521.htm
University Of Michigan. "Can Patents Stifle Innovation In Biomedical Research?." ScienceDaily. www.sciencedaily.com/releases/1998/05/980506080521.htm (accessed October 22, 2014).

Share This



More Science News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Thanks, Marty McFly! Hoverboards Could Be Coming In 2015

Thanks, Marty McFly! Hoverboards Could Be Coming In 2015

Newsy (Oct. 21, 2014) If you've ever watched "Back to the Future Part II" and wanted to get your hands on a hoverboard, well, you might soon be in luck. Video provided by Newsy
Powered by NewsLook.com
CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
Robots to Fly Planes Where Humans Can't

Robots to Fly Planes Where Humans Can't

Reuters - Innovations Video Online (Oct. 21, 2014) Researchers in South Korea are developing a robotic pilot that could potentially replace humans in the cockpit. Unlike drones and autopilot programs which are configured for specific aircraft, the robots' humanoid design will allow it to fly any type of plane with no additional sensors. Ben Gruber reports. Video provided by Reuters
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins